|
|
Previous Article | Table of Contents | Next Article 
Characterization of the p67phox gene: genomic organization and restriction
fragment length polymorphism analysis for prenatal diagnosis in chronic
granulomatous disease
RT Kenney, HL Malech, ND Epstein, RL Roberts and TL Leto
Laboratory of Host Defenses, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, Bethesda, MD 20892.
The genetic defect in the p67phox-deficient form of chronic granulomatous
disease (CGD) follows an autosomal recessive pattern of inheritance. When
genomic DNA from normal individuals is digested with HindIII and probed
with p67phox cDNA an allelic restriction fragment length polymorphism
(RFLP) of 4.0 kb or 2.3 kb is detected. We cloned and characterized the
p67phox gene using the cDNA and sequenced the exon/intron boundaries,
mapping 16 exons on the 40-kb gene. The polymorphic region was then
sequenced to identify the inheritance pattern of amniocentesis-derived
fetal cells by genomic amplification. The proband, a 9-year-old female
patient with p67phox-deficient CGD, and her phenotypically normal mother
are homozygous for the RFLP marker, whereas the father and two brothers are
heterozygous. The fetus was shown to be heterozygous as well, showing it
had inherited at least one normal p67phox gene from the father and that it
was predicted to have a normal phenotype. Cord blood samples at birth
showed normal oxidative function. Amplification allows rapid detection of
the inheritance pattern for fetal diagnosis in informative families. We
report the genomic structure of p67phox and an amplification-based method
for detection of the marker on chromosome 1q25, used here for prenatal
diagnosis of CGD.
Volume 82,
Issue 12,
pp. 3739-3744,
12/15/1993
Copyright © 1993 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. A. Eklund, I. Goldenberg, Y. Lu, J. Andrejic, and R. Kakar
SHP1 Protein-tyrosine Phosphatase Regulates HoxA10 DNA Binding and Transcriptional Repression Activity in Undifferentiated Myeloid Cells
J. Biol. Chem.,
September 20, 2002;
277(39):
36878 - 36888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Gauss, P. L. Bunger, and M. T. Quinn
AP-1 is essential for p67phox promoter activity
J. Leukoc. Biol.,
January 1, 2002;
71(1):
163 - 172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-L. Li, A. J. Valente, L. Wang, M. J. Gamez, and R. A. Clark
Transcriptional Regulation of the p67phox Gene. ROLE OF AP-1 IN CONCERT WITH MYELOID-SPECIFIC TRANSCRIPTION FACTORS
J. Biol. Chem.,
October 12, 2001;
276(42):
39368 - 39378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Eklund and R. Kakar
Recruitment of CREB-Binding Protein by PU.1, IFN-Regulatory Factor-1, and the IFN Consensus Sequence-Binding Protein Is Necessary for IFN-{gamma}-Induced p67phox and gp91phox Expression
J. Immunol.,
December 1, 1999;
163(11):
6095 - 6105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Patino, J. Rae, D. Noack, R. Erickson, J. Ding, D. G. de Olarte, and J. T. Curnutte
Molecular Characterization of Autosomal Recessive Chronic Granulomatous Disease Caused by a Defect of the Nicotinamide Adenine Dinucleotide Phosphate (Reduced Form) Oxidase Component p67-phox
Blood,
October 1, 1999;
94(7):
2505 - 2514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Kautz, R. Kakar, E. David, and E. A. Eklund
SHP1 Protein-tyrosine Phosphatase Inhibits gp91PHOX and p67PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes
J. Biol. Chem.,
October 5, 2001;
276(41):
37868 - 37878.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|